Cargando…

Histoplasmosis in African children: clinical features, diagnosis and treatment

Most of the reviews on histoplasmosis documented in literature have been in the adult population. Very few studies highlight the peculiarities associated with histoplasmosis in Africa especially in the pediatric population. This review addresses the above concerns with clinical summaries and diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekeng, Bassey Ewa, Edem, Kevin, Akintan, Patricia, Oladele, Rita O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785273/
https://www.ncbi.nlm.nih.gov/pubmed/35083042
http://dx.doi.org/10.1177/20499361211068592
_version_ 1784638927074754560
author Ekeng, Bassey Ewa
Edem, Kevin
Akintan, Patricia
Oladele, Rita O.
author_facet Ekeng, Bassey Ewa
Edem, Kevin
Akintan, Patricia
Oladele, Rita O.
author_sort Ekeng, Bassey Ewa
collection PubMed
description Most of the reviews on histoplasmosis documented in literature have been in the adult population. Very few studies highlight the peculiarities associated with histoplasmosis in Africa especially in the pediatric population. This review addresses the above concerns with clinical summaries and diagnosis of some case reports of histoplasmosis in African children. We highlighted 44 case reports of histoplasmosis in African children (1950–2021) distributed across Western Africa (38.6%, n = 17), Eastern Africa (9.1%, n = 4), Southern Africa (9.1%, n = 4), and Central Africa (43.2%, n = 19). No case report was found from Northern Africa. The age range was 1–17 years, with a mean of 9.2. Of the 44 case reports, 8 cases (18.2%, 8/44) were caused by Histoplasma capsulatum var capsulatum, 33 cases (75%, 33/44) were caused by Histoplasma capsulatum var duboisii, and specie identification was not found in 3 cases. Only three (6.8%) cases were HIV positive; 56.8% (25/44) were disseminated histoplasmosis, pulmonary histoplasmosis accounted for just one case (2.3%, 1/44). Extrapulmonary presentation included skin lesions (ulcers, fistulas, nodules, patches, pigmentations, papules, and abscesses), bone lesions, osteoarthritis, and fractures. The commonest sites affected were skin (n = 29, 65.9%), bones (n = 20, 45.5%), and lymph nodes (n = 15, 34.1%). Histopathology was the commonest diagnostic method (n = 33, 75%). Amphotericin B was first-line therapy in 45.5% of the cases (n = 20) followed by ketoconazole (20.5%, n = 9); 27 cases (61.4%) had favorable outcomes, 8 cases (18.2%) had fatal outcomes, while in 9 cases, the outcome was not revealed. This review revealed several cases of histoplasmosis misdiagnosed as other conditions including tuberculosis (n = 3, 6.8%), pneumonia (n = 1, 2.3%), cancers (n = 4, 9.1%), nephritic syndrome (n = 1, 2.3%), leishmaniasis (n = 1, 2.3%), and hyperreactive malarial splenomegaly syndrome (n = 1, 2.3%). In addition, histoplasmosis was not considered in some case reports even when symptoms were suggestive. Diagnosis of histoplasmosis was made at autopsy with postmortem findings suggestive of histoplasmosis (n = 3, 6.8%). This report highlights the need for a paradigm shift on the part of pediatricians in Africa. They need to look beyond clinical conditions considered common in our environment for this age group and evaluate for other diseases including histoplasmosis.
format Online
Article
Text
id pubmed-8785273
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87852732022-01-25 Histoplasmosis in African children: clinical features, diagnosis and treatment Ekeng, Bassey Ewa Edem, Kevin Akintan, Patricia Oladele, Rita O. Ther Adv Infect Dis Fungal Diseases in Africa: Epidemiologic, Diagnostic and Therapeutic Advances Most of the reviews on histoplasmosis documented in literature have been in the adult population. Very few studies highlight the peculiarities associated with histoplasmosis in Africa especially in the pediatric population. This review addresses the above concerns with clinical summaries and diagnosis of some case reports of histoplasmosis in African children. We highlighted 44 case reports of histoplasmosis in African children (1950–2021) distributed across Western Africa (38.6%, n = 17), Eastern Africa (9.1%, n = 4), Southern Africa (9.1%, n = 4), and Central Africa (43.2%, n = 19). No case report was found from Northern Africa. The age range was 1–17 years, with a mean of 9.2. Of the 44 case reports, 8 cases (18.2%, 8/44) were caused by Histoplasma capsulatum var capsulatum, 33 cases (75%, 33/44) were caused by Histoplasma capsulatum var duboisii, and specie identification was not found in 3 cases. Only three (6.8%) cases were HIV positive; 56.8% (25/44) were disseminated histoplasmosis, pulmonary histoplasmosis accounted for just one case (2.3%, 1/44). Extrapulmonary presentation included skin lesions (ulcers, fistulas, nodules, patches, pigmentations, papules, and abscesses), bone lesions, osteoarthritis, and fractures. The commonest sites affected were skin (n = 29, 65.9%), bones (n = 20, 45.5%), and lymph nodes (n = 15, 34.1%). Histopathology was the commonest diagnostic method (n = 33, 75%). Amphotericin B was first-line therapy in 45.5% of the cases (n = 20) followed by ketoconazole (20.5%, n = 9); 27 cases (61.4%) had favorable outcomes, 8 cases (18.2%) had fatal outcomes, while in 9 cases, the outcome was not revealed. This review revealed several cases of histoplasmosis misdiagnosed as other conditions including tuberculosis (n = 3, 6.8%), pneumonia (n = 1, 2.3%), cancers (n = 4, 9.1%), nephritic syndrome (n = 1, 2.3%), leishmaniasis (n = 1, 2.3%), and hyperreactive malarial splenomegaly syndrome (n = 1, 2.3%). In addition, histoplasmosis was not considered in some case reports even when symptoms were suggestive. Diagnosis of histoplasmosis was made at autopsy with postmortem findings suggestive of histoplasmosis (n = 3, 6.8%). This report highlights the need for a paradigm shift on the part of pediatricians in Africa. They need to look beyond clinical conditions considered common in our environment for this age group and evaluate for other diseases including histoplasmosis. SAGE Publications 2022-01-21 /pmc/articles/PMC8785273/ /pubmed/35083042 http://dx.doi.org/10.1177/20499361211068592 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Fungal Diseases in Africa: Epidemiologic, Diagnostic and Therapeutic Advances
Ekeng, Bassey Ewa
Edem, Kevin
Akintan, Patricia
Oladele, Rita O.
Histoplasmosis in African children: clinical features, diagnosis and treatment
title Histoplasmosis in African children: clinical features, diagnosis and treatment
title_full Histoplasmosis in African children: clinical features, diagnosis and treatment
title_fullStr Histoplasmosis in African children: clinical features, diagnosis and treatment
title_full_unstemmed Histoplasmosis in African children: clinical features, diagnosis and treatment
title_short Histoplasmosis in African children: clinical features, diagnosis and treatment
title_sort histoplasmosis in african children: clinical features, diagnosis and treatment
topic Fungal Diseases in Africa: Epidemiologic, Diagnostic and Therapeutic Advances
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785273/
https://www.ncbi.nlm.nih.gov/pubmed/35083042
http://dx.doi.org/10.1177/20499361211068592
work_keys_str_mv AT ekengbasseyewa histoplasmosisinafricanchildrenclinicalfeaturesdiagnosisandtreatment
AT edemkevin histoplasmosisinafricanchildrenclinicalfeaturesdiagnosisandtreatment
AT akintanpatricia histoplasmosisinafricanchildrenclinicalfeaturesdiagnosisandtreatment
AT oladeleritao histoplasmosisinafricanchildrenclinicalfeaturesdiagnosisandtreatment